Bio-Rad Laboratories, Inc. (BIO) Stock Overview
Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Bio-Rad Laboratories, Inc. (BIO)
Key Financials
Key Financials
Market Cap
7.9B
P/E Ratio
47.22
EPS (TTM)
$6.00
ROE
0.02%
BIO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Bio-Rad Laboratories, Inc. (BIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 52.19, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $150.39.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 47.22 and a market capitalization of 7.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.